Why the study?
Surgery for isolated TR is burdened by high mortality and performed in few patients, while transcatheter therapies are safe, effective, and provide better outcomes than medical therapy.
Transcatheter therapies for tricuspid regurgitation are emerging as safe and effective alternatives to high-risk surgery or medical therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: